{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:38:01Z","timestamp":1793277481093,"version":"4.5.0"},"reference-count":150,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.fertnstert.2026.10.005","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:47:35Z","timestamp":1791906455000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fertility preservation after gonadotoxic treatment: current evidence, feasibility, and outcomes"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-2040-7207","authenticated-orcid":false,"given":"Emanuela","family":"Angelini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0914-7757","authenticated-orcid":false,"given":"Kutluk H.","family":"Oktay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2026.10.005_bib1","doi-asserted-by":"crossref","first-page":"10159","DOI":"10.1158\/0008-5472.CAN-07-2042","article-title":"A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve","volume":"67","author":"Oktem","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib2","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.23071","article-title":"Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function","volume":"110","author":"Oktem","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib3","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2217\/fon-2016-0176","article-title":"Chemotherapy-induced damage to ovary: mechanisms and clinical impact","volume":"12","author":"Bedoschi","year":"2016","journal-title":"Future Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib4","doi-asserted-by":"crossref","first-page":"782","DOI":"10.18632\/aging.100363","article-title":"Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise","volume":"3","author":"Soleimani","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib5","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/molehr\/gaaa043","article-title":"Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging","volume":"26","author":"Szyma\u0144ska","year":"2020","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib6","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/s41598-020-79643-x","article-title":"Individual-oocyte transcriptomic analysis shows that genotoxic chemotherapy depletes human primordial follicle reserve in vivo by triggering proapoptotic pathways without growth activation","volume":"11","author":"Titus","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1530\/REP-07-0054","article-title":"p63 null mutation protects mouse oocytes from radio-induced apoptosis","volume":"135","author":"Livera","year":"2008","journal-title":"Reproduction"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib8","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1089\/jayao.2023.0111","article-title":"Ovarian insufficiency and fertility preservation during and after childhood cancer treatment","volume":"13","author":"Foster","year":"2024","journal-title":"J Adolesc Young Adult Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib9","doi-asserted-by":"crossref","DOI":"10.1530\/RAF-22-0123","article-title":"The future of fertility preservation for women treated with chemotherapy","volume":"4","author":"Alesi","year":"2023","journal-title":"Reprod Fertil"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib10","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/pbc.24679","article-title":"The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study","volume":"61","author":"Green","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib11","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1089\/jayao.2020.0012","article-title":"Standardizing risk assessment for treatment-related gonadal insufficiency and infertility in childhood adolescent and young adult cancer: the Pediatric Initiative Network Risk Stratification System","volume":"9","author":"Meacham","year":"2020","journal-title":"J Adolesc Young Adult Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070117","article-title":"Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin","volume":"8","author":"Morgan","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib13","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/molehr\/gaaa008","article-title":"Comparative gonadotoxicity of the chemotherapy drugs cisplatin and carboplatin on prepubertal mouse gonads","volume":"26","author":"Allen","year":"2020","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib14","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1038\/s41401-021-00687-4","article-title":"Mitochondrial proteome of mouse oocytes and cisplatin-induced shifts in protein profile","volume":"42","author":"Zhang","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib15","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/cdd.2013.31","article-title":"Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network","volume":"20","author":"Kim","year":"2013","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib16","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41419-019-1961-y","article-title":"Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertility","volume":"10","author":"Bellusci","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/molehr\/gaz020","article-title":"Cisplatin- and cyclophosphamide-induced primordial follicle depletion is caused by direct damage to oocytes","volume":"25","author":"Nguyen","year":"2019","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib18","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.fertnstert.2021.12.007","article-title":"Impact of chemotherapy on the ovarian reserve: are all primordial follicles created equal?","volume":"117","author":"Oktay","year":"2022","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib19","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature05337","article-title":"p63 protects the female germ line during meiotic arrest","volume":"444","author":"Suh","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib20","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nm.2033","article-title":"Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death","volume":"15","author":"Gonfloni","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib21","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.molcel.2012.08.017","article-title":"DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa","volume":"48","author":"Kerr","year":"2012","journal-title":"Mol Cell"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41594-018-0035-7","article-title":"Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63","volume":"25","author":"Tuppi","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib23","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41419-018-0633-7","article-title":"Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility","volume":"9","author":"Nguyen","year":"2018","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1530\/JOE-18-0370","article-title":"Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide","volume":"240","author":"Luan","year":"2019","journal-title":"J Endocrinol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib25","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s10815-021-02184-3","article-title":"DNA repair in primordial follicle oocytes following cisplatin treatment","volume":"38","author":"Nguyen","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humrep\/det391","article-title":"Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death","volume":"29","author":"Li","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib27","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/GRF.0b013e3181f96b54","article-title":"Toxicity of chemotherapy and radiation on female reproduction","volume":"53","author":"Meirow","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib28","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s10815-020-01792-9","article-title":"Looking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments","volume":"37","author":"Garg","year":"2020","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib29","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/humrep\/deaa128","article-title":"The PARP inhibitor, olaparib, depletes the ovarian reserve in mice: implications for fertility preservation","volume":"35","author":"Winship","year":"2020","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/eci.13779","article-title":"Risk of gonadotoxicity with immunotherapy and targeted agents remains an unsolved but crucial issue","volume":"52","author":"Lambertini","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib31","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.freeradbiomed.2017.05.006","article-title":"Cyclophosphamide and acrolein induced oxidative stress leading to deterioration of metaphase II mouse oocyte quality","volume":"110","author":"Jeelani","year":"2017","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib32","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1007\/s11357-023-00728-2","article-title":"Increased cellular senescence in doxorubicin-induced murine ovarian injury: effect of senolytics","volume":"45","author":"Gao","year":"2023","journal-title":"Geroscience"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41419-023-05859-0","article-title":"Chemotherapy impairs ovarian function through excessive ROS-induced ferroptosis","volume":"14","author":"Zhang","year":"2023","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib34","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/humupd\/dmae020","article-title":"Ovarian microenvironment: challenges and opportunities in protecting against chemotherapy-associated ovarian damage","volume":"30","author":"Guo","year":"2024","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib35","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20181424","article-title":"Epigallocatechin-3-gallate inhibits doxorubicin-induced inflammation on human ovarian tissue","volume":"39","author":"Fabbri","year":"2019","journal-title":"Biosci Rep"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jri.2022.103491","article-title":"Evidence of cancer therapy-induced chronic inflammation in the ovary across multiple species: a potential cause of persistent tissue damage and follicle depletion","volume":"150","author":"Du","year":"2022","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005402","article-title":"Cyclophosphamide triggers follicle activation and \"burnout\"; AS101 prevents follicle loss and preserves fertility","volume":"5","author":"Kalich-Philosoph","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144245","article-title":"Cisplatin induces overactivation of the dormant primordial follicle through the PTEN\/AKT\/FOXO3a pathway, which leads to loss of ovarian reserve in mice","volume":"10","author":"Chang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib39","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.rbmo.2016.10.005","article-title":"Short-term exposure of human ovarian follicles to cyclophosphamide metabolites seems to promote follicular activation in vitro","volume":"34","author":"Lande","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib40","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.fertnstert.2020.11.040","article-title":"Ovaries of patients recently treated with alkylating agent chemotherapy indicate the presence of acute follicle activation, elucidating its role among other proposed mechanisms of follicle loss","volume":"115","author":"Shai","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/humrep\/deaf024","article-title":"Does gonadotoxic chemotherapy deplete the ovarian reserve through activation of primordial follicles?","volume":"40","author":"Erden","year":"2025","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib42","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1093\/humrep\/dez125","article-title":"Impact of first-line cancer treatment on the follicle quality in cryopreserved ovarian samples from girls and young women","volume":"34","author":"Pampanini","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib43","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/humrep\/dead013","article-title":"Impact of first chemotherapy exposure on follicle activation and survival in human cryopreserved ovarian tissue","volume":"38","author":"Devos","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib44","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/cyt.13194","article-title":"When to cryopreserve ovarian tissue: determining the effects of chemotherapy on the ovarian reserve by studying follicular density and apoptosis","volume":"34","author":"Labrune","year":"2023","journal-title":"Cytopathology"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib45","doi-asserted-by":"crossref","first-page":"13885","DOI":"10.1096\/fj.202001461RR","article-title":"Continuous treatment with cisplatin induces the oocyte death of primordial follicles without activation","volume":"34","author":"Eldani","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib46","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/dem027","article-title":"Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury","volume":"22","author":"Meirow","year":"2007","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib47","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1634\/theoncologist.2012-0172","article-title":"Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity","volume":"17","author":"Ben-Aharon","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib48","first-page":"1209","article-title":"The impact of systemic oncological treatments on the fertility of adolescents and young adults: a systematic review","volume":"13","author":"Himpe","year":"2023","journal-title":"Life (Basel)"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib49","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/j.fertnstert.2007.09.048","article-title":"Impact of breast cancer chemotherapy on ovarian reserve: a prospective observational analysis by menstrual history and ovarian reserve markers","volume":"90","author":"Reh","year":"2008","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib50","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.rbmo.2017.06.005","article-title":"Influence of adjuvant chemotherapy on anti-M\u00fcllerian hormone in women below 35 years treated for early breast cancer","volume":"35","author":"Perdrix","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib51","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/humrep\/deg016","article-title":"The radiosensitivity of the human oocyte","volume":"18","author":"Wallace","year":"2003","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib52","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijrobp.2004.11.038","article-title":"Predicting age of ovarian failure after radiation to a field that includes the ovaries","volume":"62","author":"Wallace","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib53","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ijrobp.2023.08.013","article-title":"Effects of radiation therapy on the female reproductive tract in childhood cancer survivors: a PENTEC comprehensive review","volume":"119","author":"Hill-Kayser","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib54","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1093\/bjr\/tqaf130","article-title":"Pregnancy outcomes in childhood cancer survivors according to uterine radiation dose and other factors","volume":"98","author":"Legrand","year":"2025","journal-title":"Br J Radiol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib55","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1210\/jc.2018-01175","article-title":"Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: an Endocrine Society clinical practice guideline","volume":"103","author":"Sklar","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib56","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1016\/j.bbmt.2019.07.039","article-title":"Updated clinical outcomes of hematopoietic stem cell transplantation using myeloablative total body irradiation with ovarian shielding to preserve fertility","volume":"25","author":"Ashizawa","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib57","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/cpt.2254","article-title":"Oncofertility information available for recently approved novel non cytotoxic and immunotherapy oncology drugs","volume":"111","author":"Volckmar","year":"2022","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib58","article-title":"Impact of immunotherapy and small molecule cancer therapy on fertility: a narrative review of current evidence, mechanisms and future directions","volume":"5","author":"Gargus","year":"2026","journal-title":"BMJ Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib59","doi-asserted-by":"crossref","first-page":"R147","DOI":"10.1530\/RAF-22-0020","article-title":"Potential ovarian toxicity and infertility risk following targeted anti-cancer therapies","volume":"3","author":"Rosario","year":"2022","journal-title":"Reprod Fertil"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgc.2026.104697","article-title":"The effects of immune checkpoint inhibitors and targeted therapies on female fertility and ovarian function: a systematic review","volume":"36","author":"Ate\u015f","year":"2026","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib61","doi-asserted-by":"crossref","first-page":"33","DOI":"10.6004\/jnccn.2022.7065","article-title":"Impact of anti-HER2 therapy alone and with weekly paclitaxel on the ovarian reserve of young women with HER2-positive breast cancer","volume":"21","author":"Lambertini","year":"2023","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s43018-022-00413-x","article-title":"Checkpoint inhibitor immunotherapy diminishes oocyte number and quality in mice","volume":"3","author":"Winship","year":"2022","journal-title":"Nat Cancer"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib63","doi-asserted-by":"crossref","DOI":"10.1093\/oncolo\/oyag048","article-title":"Impact of immune checkpoint inhibition on ovarian reserve","volume":"31","author":"Buchbinder","year":"2026","journal-title":"Oncologist"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib64","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10549-025-07702-w","article-title":"Impact of pembrolizumab on ovarian function in young triple-negative breast cancer patients treated with chemo-immunotherapy","volume":"212","author":"Perdrix","year":"2025","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib65","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ejca.2020.11.032","article-title":"Cancer survivorship: reproductive health outcomes should be included in standard toxicity assessments","volume":"144","author":"Anderson","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib66","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/cncr.35108","article-title":"Fertility preservation before and after cancer treatment in children, adolescents, and young adults","volume":"130","author":"Yang","year":"2024","journal-title":"Cancer"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib67","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1200\/JCO-24-02782","article-title":"Fertility preservation in people with cancer: ASCO guideline update","volume":"43","author":"Su","year":"2025","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib68","article-title":"ESHRE guideline: female fertility preservation","volume":"2020","author":"Anderson","year":"2020","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib69","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2023.103767","article-title":"Fertility preservation in patients undergoing gonadotoxic treatments: a Canadian Fertility and Andrology Society clinical practice guideline","volume":"48","author":"Roberts","year":"2024","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib70","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO clinical practice guidelines","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib71","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ijgo.70426","article-title":"Cancer and fertility management: FIGO best practice advice","volume":"171","author":"Purandare","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib72","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/humrep\/deab035","article-title":"Treatment-related fertility impairment in long-term female childhood, adolescent and young adult cancer survivors: investigating dose-effect relationships in a European case-control study (PanCareLIFE)","volume":"36","author":"van den Berg","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.574263","article-title":"The clinical value and interpretation of anti-M\u00fcllerian hormone in women with cancer","volume":"11","author":"Anderson","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib74","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/humupd\/dmac004","article-title":"Anti-M\u00fcllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review","volume":"28","author":"Anderson","year":"2022","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib75","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10549-021-06508-w","article-title":"Diagnostic and predictive accuracy of anti-mullerian hormone for ovarian function after chemotherapy in premenopausal women with early breast cancer","volume":"192","author":"Anderson","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2016.12.008","article-title":"Anti-M\u00fcllerian hormone levels and evolution in women of reproductive age with breast cancer treated with chemotherapy","volume":"74","author":"Fr\u00e9our","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib77","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1093\/humrep\/deae112","article-title":"The impact of treatment for childhood classical Hodgkin lymphoma according to the EuroNet-PHL-C2 protocol on serum anti-M\u00fcllerian hormone","volume":"39","author":"Drechsel","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2025.104514","article-title":"High impact of chemotherapy on ovarian reserve in breast cancer survivors of reproductive age: a systematic review and meta-analysis","volume":"82","author":"Weidlinger","year":"2025","journal-title":"Breast"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib79","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10549-020-05933-7","article-title":"Impact of adjuvant chemotherapy or tamoxifen-alone on the ovarian reserve of young women with breast cancer","volume":"185","author":"Goldfarb","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3004925","article-title":"Impairment of BRCA1-related DNA double-strand break repair leads to ovarian aging in mice and humans","volume":"5","author":"Titus","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib81","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/humupd\/dmz043","article-title":"BRCA-related ATM-mediated DNA double-strand break repair and ovarian aging","volume":"26","author":"Turan","year":"2020","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib82","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1200\/JCO.20.02880","article-title":"Association of germline BRCA pathogenic variants with diminished ovarian reserve: a meta-analysis of individual patient-level data","volume":"39","author":"Turan","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib83","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1200\/JCO.2013.53.5369","article-title":"Age-related decline in DNA repair function explains diminished ovarian reserve, earlier menopause, and possible oocyte vulnerability to chemotherapy in women with BRCA mutations","volume":"32","author":"Oktay","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib84","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.fertnstert.2020.01.033","article-title":"Increased chemotherapy-induced ovarian reserve loss in women with germline BRCA mutations due to oocyte deoxyribonucleic acid double strand break repair deficiency","volume":"113","author":"Oktay","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib85","doi-asserted-by":"crossref","first-page":"19225","DOI":"10.1002\/cam4.6527","article-title":"A prospective longitudinal analysis of the predictors of amenorrhea after breast cancer chemotherapy: impact of BRCA pathogenic variants","volume":"12","author":"Oktay","year":"2023","journal-title":"Cancer Med"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib86","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.fertnstert.2024.05.002","article-title":"Interindividual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors - a genome-wide association study: results from PanCareLIFE","volume":"122","author":"van der Perk","year":"2024","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib87","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.3390\/cancers16162793","article-title":"Molecular factors predicting ovarian chemotoxicity in fertile women: a systematic review","volume":"16","author":"Raimondo","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib88","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1093\/humrep\/des143","article-title":"Ovarian reserve and response to IVF and in vitro maturation treatment following chemotherapy","volume":"27","author":"Das","year":"2012","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib89","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1007\/s10815-015-0575-2","article-title":"Outcomes of ovarian stimulation after treatment with chemotherapy","volume":"32","author":"Chan","year":"2015","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib90","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s13048-023-01250-x","article-title":"Fertility preservation after gonadotoxic treatments for cancer and autoimmune diseases","volume":"16","author":"Saito","year":"2023","journal-title":"J Ovarian Res"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib91","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoaf023","article-title":"Controlled ovarian stimulation for oocyte preservation in childhood cancer survivors who have undergone chemotherapy","volume":"2025","author":"Shapira","year":"2025","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib92","article-title":"Cyclophosphamide exposure causes long-term detrimental effect of oocytes developmental competence through affecting the epigenetic modification and maternal factors' transcription during oocyte growth","volume":"9","author":"Yang","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib93","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.fertnstert.2025.12.001","article-title":"Fertility preservation in patients with medical indications: a committee opinion","volume":"125","year":"2026","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib94","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/humrep\/16.4.632","article-title":"Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations","volume":"16","author":"Meirow","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib95","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4137\/CMRH.S10848","article-title":"Fertility preservation options after gonadotoxic chemotherapy","volume":"7","author":"Hyman","year":"2013","journal-title":"Clin Med Insights Reprod Health"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.fertnstert.2011.01.030","article-title":"Random-start controlled ovarian hyperstimulation for emergency fertility preservation in letrozole cycles","volume":"95","author":"S\u00f6nmezer","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.rbmo.2023.103337","article-title":"Random start ovarian stimulation before gonadotoxic therapies in women with cancer: a systematic review and meta-analysis","volume":"47","author":"S\u00f6nmezer","year":"2023","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib98","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s10815-023-02882-0","article-title":"Outcomes of random-start letrozole protocol with PGT-A in women with breast cancer undergoing fertility preservation","volume":"40","author":"Turan","year":"2023","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib99","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.fertnstert.2013.08.030","article-title":"Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients","volume":"100","author":"Turan","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib100","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib101","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1200\/JCO.2014.59.3723","article-title":"Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer","volume":"33","author":"Oktay","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib102","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.rbmo.2010.03.004","article-title":"GnRH agonist trigger for women with breast cancer undergoing fertility preservation by aromatase inhibitor\/FSH stimulation","volume":"20","author":"Oktay","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib103","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s10815-014-0248-6","article-title":"Triggering final oocyte maturation with gonadotropin-releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (hCG) in breast cancer patients undergoing fertility preservation: an extended experience","volume":"31","author":"Reddy","year":"2014","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib104","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1210\/jc.2015-3878","article-title":"Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer","volume":"101","author":"Kim","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.fertnstert.2016.04.031","article-title":"Transplantations of frozen-thawed ovarian tissue demonstrate high reproductive performance and the need to revise restrictive criteria","volume":"106","author":"Meirow","year":"2016","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib106","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/humrep\/dez047","article-title":"Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantation","volume":"34","author":"Poirot","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib107","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/humupd\/dmaf026","article-title":"Female fertility preservation: 25 years of progress, expanding indications and future prospects","volume":"32","author":"Sonmezer","year":"2026","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib108","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJM200006223422516","article-title":"Ovarian function after transplantation of frozen, banked autologous ovarian tissue","volume":"342","author":"Oktay","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib109","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/S0015-0282(01)01776-9","article-title":"A technique for laparoscopic transplantation of frozen-banked ovarian tissue","volume":"75","author":"Oktay","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib110","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.fertnstert.2008.10.006","article-title":"Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience","volume":"93","author":"Oktay","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib111","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.fertnstert.2023.10.015","article-title":"Comparison of orthotopic and heterotopic autologous ovarian tissue transplantation outcomes","volume":"121","author":"Oktay","year":"2024","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib112","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molmed.2021.01.005","article-title":"Delaying reproductive aging by ovarian tissue cryopreservation and transplantation: is it prime time?","volume":"27","author":"Oktay","year":"2021","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib113","doi-asserted-by":"crossref","first-page":"4311","DOI":"10.1182\/blood-2012-01-403022","article-title":"Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells","volume":"120","author":"Greve","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib114","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.fertnstert.2017.09.001","article-title":"First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination","volume":"109","author":"Shapira","year":"2018","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib115","article-title":"Evaluating the safety and efficacy of cryopreserved ovarian tissue transplantation in leukemia patients with different bone marrow remission status using xenotransplantation","volume":"15","author":"Li","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib116","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.3324\/haematol.2018.211094","article-title":"Post-transplant outcome of ovarian tissue cryopreserved after chemotherapy in hematologic malignancies","volume":"104","author":"Poirot","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib117","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.fertnstert.2021.05.096","article-title":"Use of cryopreserved ovarian tissue in the Danish fertility preservation cohort","volume":"116","author":"Kristensen","year":"2021","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib118","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s10815-018-1315-1","article-title":"Cryopreservation and transplantation of ovarian tissue: results from one center in the US","volume":"35","author":"Silber","year":"2018","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib119","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3324\/haematol.2021.278828","article-title":"Successful pregnancies after transplantation of ovarian tissue retrieved and cryopreserved at time of childhood acute lymphoblastic leukemia\u2013a case report","volume":"106","author":"Rodriguez-Wallberg","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2023.08.032","article-title":"Safety of ovarian cryopreservation and transplantation in patients with acute leukemia: a case series","volume":"230","author":"S\u00f6nmezer","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib121","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s10815-025-03447-z","article-title":"Cryopreserved ovarian tissue autotransplantation in an acute myeloid leukaemia survivor following extensive minimal residual disease screening: first reported live birth in Europe","volume":"42","author":"Soares","year":"2025","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib122","first-page":"1044","article-title":"Ovarian tissue autotransplantation in acute leukemia: balancing the risk of relapse and the hope of parenthood","volume":"111","author":"Chevillon","year":"2026","journal-title":"Haematologica"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib123","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1095\/biolreprod54.1.197","article-title":"Development in vitro of mouse oocytes from primordial follicles","volume":"54","author":"Eppig","year":"1996","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib124","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/molehr\/gay002","article-title":"Metaphase II oocytes from human unilaminar follicles grown in a multi-step culture system","volume":"24","author":"McLaughlin","year":"2018","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib125","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1152\/physrev.00032.2022","article-title":"Making a good egg: human oocyte health, aging, and in vitro development","volume":"103","author":"Telfer","year":"2023","journal-title":"Physiol Rev"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib126","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3390\/ijms25031510","article-title":"In vitro growth of human follicles: current and future perspectives","volume":"25","author":"Malo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib127","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/humrep\/dey384","article-title":"Enhancing the safety of ovarian cortex autotransplantation: cancer cells are purged completely from human ovarian tissue fragments by pharmacological inhibition of YAP\/TAZ oncoproteins","volume":"34","author":"Mulder","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib128","article-title":"Ex vivo purging of cancer cells from ovarian tissue using photodynamic therapy: a novel strategy to restore fertility in leukemia patients","volume":"2","author":"Moghassemi","year":"2023","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib129","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.rbmo.2010.01.012","article-title":"In vitro maturation improves oocyte or embryo cryopreservation outcome in breast cancer patients undergoing ovarian stimulation for fertility preservation","volume":"20","author":"Oktay","year":"2010","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib130","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hox001","article-title":"Ovarian tissue cryopreservation for fertility preservation: clinical and research perspectives","volume":"2017","author":"Anderson","year":"2017","journal-title":"Hum Reprod Open"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib131","series-title":"Principles and practice of ovarian tissue cryopreservation and transplantation","first-page":"61","article-title":"Oocyte retrieval and in vitro maturation from the harvested tissue before cryopreservation","author":"Sugishita","year":"2022"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib132","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/humrep\/dead142","article-title":"Prior exposure to chemotherapy does not reduce the in vitro maturation potential of oocytes obtained from ovarian cortex in cancer patients","volume":"38","author":"Karavani","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib133","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s10815-021-02133-0","article-title":"Conception after chemotherapy: post-chemotherapy method of conception and pregnancy outcomes in breast cancer patients","volume":"38","author":"Abel","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib134","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/AOG.0000000000001248","article-title":"Successful oocyte cryopreservation in reproductive-aged cancer survivors","volume":"127","author":"Druckenmiller","year":"2016","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib135","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1177\/1933719117702251","article-title":"Current success and efficiency of autologous ovarian transplantation: a meta-analysis","volume":"24","author":"Pacheco","year":"2017","journal-title":"Reprod Sci"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib136","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/humupd\/dmac003","article-title":"Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis","volume":"28","author":"Khattak","year":"2022","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib137","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/humrep\/deac249","article-title":"Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation","volume":"38","author":"Fraison","year":"2023","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib138","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1093\/humrep\/deae243","article-title":"Outcomes of female fertility preservation with cryopreservation of oocytes or embryos in the Netherlands: a population-based study","volume":"39","author":"Ter Welle-Butalid","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib139","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1007\/s10815-025-03522-5","article-title":"Fertility preservation through oocyte or embryo vitrification prior to oncological treatment: a 12-year experience","volume":"42","author":"Zimmermann","year":"2025","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib140","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1002\/ijgo.70139","article-title":"Pregnancy after cancer: FIGO Best practice advice","volume":"169","author":"Maxwell","year":"2025","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib141","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/JCO.2011.37.2938","article-title":"Congenital anomalies in the children of cancer survivors: a report from the childhood cancer survivor study","volume":"30","author":"Signorello","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib142","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1001\/jamaoncol.2017.0029","article-title":"Birth outcomes among adolescent and young adult cancer survivors","volume":"3","author":"Anderson","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib143","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1158\/1055-9965.EPI-09-0287","article-title":"Pregnancy outcomes among adult survivors of childhood cancer in the British Childhood Cancer Survivor Study","volume":"18","author":"Reulen","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib144","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ajog.2020.05.058","article-title":"Counseling and surveillance of obstetrical risks for female childhood, adolescent, and young adult cancer survivors: recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"224","author":"van der Kooi","year":"2021","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib145","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/humrep\/dead255","article-title":"Anti-M\u00fcllerian hormone attenuates both cyclophosphamide-induced damage and PI3K signalling activation, while rapamycin attenuates only PI3K signalling activation, in human ovarian cortex in vitro","volume":"39","author":"Rosario","year":"2024","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0019475","article-title":"Enhancement of neoangiogenesis and follicle survival by sphingosine-1-phosphate in human ovarian tissue xenotransplants","volume":"6","author":"Soleimani","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib147","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122768","article-title":"Local delivery of platelet-derived factors mitigates ischemia and preserves ovarian function through angiogenic modulation: a personalized regenerative strategy for fertility preservation","volume":"313","author":"Chung","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib148","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202403944","article-title":"Ovarian function restoration with biomimetic scaffold incorporating angiogenic molecules and antioxidant in chemotherapy-induced perimenopausal model","volume":"14","author":"Kim","year":"2025","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.10.001","article-title":"First pregnancies, live birth, and in vitro fertilization outcomes after transplantation of frozen-banked ovarian tissue with a human extracellular matrix scaffold using robot-assisted minimally invasive surgery","volume":"214","author":"Oktay","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2026.10.005_bib150","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.fertnstert.2021.08.034","article-title":"Ovarian transplantation with robotic surgery and a neovascularizing human extracellular matrix scaffold: a case series in comparison to meta-analytic data","volume":"117","author":"Oktay","year":"2022","journal-title":"Fertil Steril"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028226018121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028226018121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:30:59Z","timestamp":1793277059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028226018121"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":150,"alternative-id":["S0015028226018121"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2026.10.005","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fertility preservation after gonadotoxic treatment: current evidence, feasibility, and outcomes","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2026.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a92026 Published by Elsevier Inc. on behalf of the American Society for Reproductive Medicine","name":"copyright","label":"Copyright"}]}}